Lee JS - Search Results

1

Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.

Fossella FV, Lee JS, Berille J, Hong WK. Fossella FV, et al. Among authors: lee js. Semin Oncol. 1995 Apr;22(2 Suppl 4):22-9. Semin Oncol. 1995. PMID: 7740327 Review.

2

Systemic treatment of non-small-cell lung cancer.

Lenzi R, Fossella FV, Lee JS. Lenzi R, et al. Among authors: lee js. Compr Ther. 1992 Mar;18(3):27-30. Compr Ther. 1992. PMID: 1315236 Review. No abstract available.

3

Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancer.

Shin DM, Dhingra HM, Lee JS, Fossella FV, Murphy WK, Hong WK. Shin DM, et al. Among authors: lee js. Am J Clin Oncol. 1992 Jun;15(3):194-9. doi: 10.1097/00000421-199206000-00003. Am J Clin Oncol. 1992. PMID: 1317094 Clinical Trial.

4

Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. J Natl Cancer Inst. 1992 Jul 1;84(13):1039-40. doi: 10.1093/jnci/84.13.1039. J Natl Cancer Inst. 1992. PMID: 1318977 Clinical Trial. No abstract available.

5

The incidence of second primary tumors in long-term survivors of small-cell lung cancer.

Heyne KH, Lippman SM, Lee JJ, Lee JS, Hong WK. Heyne KH, et al. Among authors: lee js, lee jj. J Clin Oncol. 1992 Oct;10(10):1519-24. doi: 10.1200/JCO.1992.10.10.1519. J Clin Oncol. 1992. PMID: 1328547

6

Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.

Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK. Shirinian M, et al. Among authors: lee js. Semin Oncol. 1992 Feb;19(1 Suppl 1):49-53. Semin Oncol. 1992. PMID: 1329212

7

Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report.

Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK. Shirinian M, et al. Among authors: lee js. Semin Oncol. 1992 Dec;19(6 Suppl 12):58-63. Semin Oncol. 1992. PMID: 1336623 Clinical Trial.

8

Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer.

Shin HJ, Lee JS, Hong WK, Shin DM. Shin HJ, et al. Among authors: lee js. Anticancer Res. 1992 Mar-Apr;12(2):367-70. Anticancer Res. 1992. PMID: 1374598

9

Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer.

Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman SM, Shin DM, Dimery IW, Glisson BS, Hong WK. Lee JS, et al. Cancer. 1991 Sep 1;68(5):959-64. doi: 10.1002/1097-0142(19910901)68:5<959::aid-cncr2820680508>3.0.co;2-v. Cancer. 1991. PMID: 1655220 Clinical Trial.

10

Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer.

Lee JS, Ro JY, Sahin AA, Hong WK, Brown BW, Mountain CF, Hittelman WN. Lee JS, et al. N Engl J Med. 1991 Apr 18;324(16):1084-90. doi: 10.1056/NEJM199104183241603. N Engl J Med. 1991. PMID: 1848917 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,755 results

Search Page

Filters